1. CRISPR du-HITI an attractive approach to targeting Long Noncoding RNA HCP5 as inhibitory factor for proliferation of ovarian cancer cell
    Zeinab Moradi et al, 2024, Functional & Integrative Genomics CrossRef
  2. The role of CEMIP in cancers and its transcriptional and post-transcriptional regulation
    Song Guo et al, 2024, PeerJ CrossRef
  3. NLRP3: Role in ischemia/reperfusion injuries
    Soudeh Ghafouri-Fard et al, 2022, Frontiers in Immunology CrossRef
  4. LncRNA HCP5 Induces Gastric Cancer Cell Proliferation, Invasion, and EMT Processes Through the miR-186-5p/WNT5A Axis Under Hypoxia
    Ming Gao et al, 2021, Frontiers in Cell and Developmental Biology CrossRef
  5. [Retracted] Silencing of Long Noncoding RNA HLA Complex P5 (HCP5) Suppresses Glioma Progression through the HCP5‐miR‐205‐Vascular Endothelial Growth Factor A Feedback Loop
    Rui Cheng et al, 2022, BioMed Research International CrossRef
  6. Long Noncoding RNA HCP5 Contributes to Nasopharyngeal Carcinoma Progression by Targeting MicroRNA-128-3p
    Gangyong Miao et al, 2022, Journal of Oncology CrossRef
  7. Research on the biological mechanism and potential application of CEMIP
    Yang Liu et al, 2023, Frontiers in Immunology CrossRef
  8. RETRACTED: LncRNA DLX6-AS1 Promotes Malignant Phenotype and Lymph Node Metastasis in Prostate Cancer by Inducing LARGE Methylation
    Zhifeng Zhao et al, 2020, Frontiers in Oncology CrossRef
  9. CEMIP, a Promising Biomarker That Promotes the Progression and Metastasis of Colorectal and Other Types of Cancer
    Kevin Domanegg et al, 2022, Cancers CrossRef
  10. Signature Panel of 11 Methylated mRNAs and 3 Methylated lncRNAs for Prediction of Recurrence-Free Survival in Prostate Cancer Patients
    Jiarong Cai et al, 2021, Pharmacogenomics and Personalized Medicine CrossRef
  11. Crosstalk between Long Non Coding RNAs, microRNAs and DNA Damage Repair in Prostate Cancer: New Therapeutic Opportunities?
    Folake Orafidiya et al, 2022, Cancers CrossRef
  12. Anti‐tumor efficacy of emodin on colorectal cancer cells via targeting lncRNA HLA complex P5
    Chongxian Yan et al, 2024, Chemical Biology & Drug Design CrossRef
  13. Long Non-coding RNAs LINC01679 as a Competitive Endogenous RNAs Inhibits the Development and Progression of Prostate Cancer via Regulating the miR-3150a-3p/SLC17A9 Axis
    Yuan-yuan Mi et al, 2021, Frontiers in Cell and Developmental Biology CrossRef
  14. The expression analysis of long non-coding RNAs and p53 as a possible genetic signature in luminal: An invasive breast ductal carcinoma
    Farkhondeh Pouresmaeili et al, 2023, Journal of Cancer Prevention & Current Research CrossRef
  15. Knockdown of Long Non-Coding RNA HCP5 Increases Radiosensitivity Through Cellular Senescence by Regulating microRNA-128 in Gliomas
    Cuihong Wang et al, 2021, Cancer Management and Research CrossRef
  16. LncRNA HCP5 acts as a miR-128-3p sponge to promote the progression of multiple myeloma through activating Wnt/β‐catenin/cyclin D1 signaling via PLAGL2
    Qinhua Liu et al, 2022, Cell Biology and Toxicology CrossRef

  17. Knockdown of lncRNA HCP5 Suppresses the Progression of Colorectal Cancer by miR-299-3p/PFN1/AKT Axis


    Ni Bai et al, 2020, Cancer Management and Research CrossRef
  18. Overexpression of UBE2C in esophageal squamous cell carcinoma tissues and molecular analysis
    Rong Li et al, 2021, BMC Cancer CrossRef